Tarantino Previews Exciting Research in HER2-Low Breast Cancer
Season 6, Episode 50, May 26, 2022, 06:49 PM
Dr Tarantino provides background on the categorization of HER2-low disease in breast cancer, issues with standardization and interpretation, historical management strategies, and ongoing research with agents including trastuzumab deruxtecan, trastuzumab duocarmazine, and disitamab vedotin.